Skip to main content
)

ACC 2021

American College of Cardiology 70th Annual Scientific Session & Expo 2021

May 15-17, 2021 | Virtual

CSL Behring was proud to support the Virtual Industry-Expert Theater at the American College of Cardiology 70th Annual Scientific Session & Expo 2021, titled Re-imagining the 90-Day High-Risk Period Post-AMI: Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization”. During this live panel discussion, distinguished experts Prof. C. Michael Gibson, Prof. Roxana Mehran, and Prof. Philippe G. Steg discussed the risk and incidence of recurrent CV events post-AMI, and the role of cholesterol efflux and ApoA-I in plaque stabilization.

Symposium Video

Re-imagining the 90-Day High-Risk Period Post-AMI: Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization

Chaired by: Prof. C. Michael Gibson

Co-presented by: Prof. Roxana Mehran and Prof. Philippe G. Steg

Duration: 53:40

Educational Resources

ACC 2021 congress highlights

Re-imagining the 90-Day High-Risk Period Post-AMI Congress Highlights

Prof. C. Michael Gibson, Prof. Roxana Mehran, and Prof. Philippe G. Steg 

Risk and Incidence of Recurrent CV Events Post-ACS: A Meta-Analysis

Cholesterol Efflux and Cardiovascular Outcomes

Listen to Prof. C. Michael Gibson as he explores the association between CEC and adverse CV events. He also discusses the potential of CEC as a novel therapeutic target to improve outcomes for patients with CV disease.

Podcast Notes:

1. Lee et al., 2021

Download Podcast

Risk and Incidence of Recurrent CV Events Post-ACS: A Meta-Analysis

Risk and Incidence of Recurrent CV Events Post-ACS: A Meta-Analysis

Listen to Prof. C. Michael Gibson discuss the risks associated with early and late recurrent events in patients with recent ACS, and the implications this could have on trial design.

Podcast Notes:

1. Chi et al., 2021

Download Podcast


Legend

  • ACS, acute coronary syndrome;AMI, acute myocardial infarction; ApoA-I, apolipoprotein A1; CEC, cholesterol efflux capacity; CV, cardiovascular.

CMD-CRP-0004
July 2022